NEULAND LABORATORIES
Back to Balance Sheet
|
NEULAND LABORATORIES Last 5 Year Long Term Provisions History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Long Term Provisions | ₹7.22 Cr | ₹7.61 Cr | ₹10 Cr | ₹12 Cr | ₹9.44 Cr |
What is the latest Long Term Provisions ratio of NEULAND LABORATORIES ?
Year | Long Term Provisions |
---|---|
Mar2025 | ₹7.22 Cr |
Mar2024 | ₹7.61 Cr |
Mar2023 | ₹10 Cr |
Mar2022 | ₹12 Cr |
Mar2021 | ₹9.44 Cr |
How is Long Term Provisions of NEULAND LABORATORIES Trending?
Years | Long Term Provisions | % Change | |
---|---|---|---|
Mar2025 | ₹7.22 Cr | -5.10 | |
Mar2024 | ₹7.61 Cr | -26.05 | |
Mar2023 | ₹10 Cr | -13.62 | |
Mar2022 | ₹12 Cr | 26.22 | |
Mar2021 | ₹9.44 Cr | - |
Compare Long Term Provisions of peers of NEULAND LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NEULAND LABORATORIES | ₹16,733.6 Cr | -5.6% | 9% | 39.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹393,731.0 Cr | -4.1% | -2.1% | -5.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹172,373.0 Cr | -2.8% | -5.9% | 29.2% | Stock Analytics | |
CIPLA | ₹122,411.0 Cr | -3.7% | 0.1% | -2.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,285.0 Cr | -4.1% | 7.3% | 14.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹102,270.0 Cr | -5.7% | -6.1% | -11.6% | Stock Analytics |
NEULAND LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NEULAND LABORATORIES | -5.6% |
9% |
39.1% |
SENSEX | 0.2% |
-2.7% |
-0.9% |
You may also like the below Video Courses